[The effect of intravenously infused ACTH on urine and plasma corticosteroids in mastopathy and breast cancer].
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D015068:17-Ketosteroids / Q000378:metabolism; D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D001798:Blood Proteins; D001941:Breast Diseases / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism*; D012739:Gonadal Steroid Hormones / Q000378:metabolism; D006801:Humans; D014556:Urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D001798:Blood Proteins; D012739:Gonadal Steroid Hormones; D000324:Adrenocorticotropic Hormone
Der Einfluss von intravenös infundiertem ACTH auf Harn- und Plasma-Corticosteroide bei Mastopathie und Brustkrebs.